Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHaleon Regulatory News (HLN)

Share Price Information for Haleon (HLN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 325.10
Bid: 324.60
Ask: 324.80
Change: 0.40 (0.12%)
Spread: 0.20 (0.062%)
Open: 324.50
High: 326.50
Low: 323.40
Prev. Close: 324.70
HLN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

19 Jul 2022 11:30

RNS Number : 9798S
Haleon PLC
19 July 2022
 

Haleon plc

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BMX86B70

Issuer Name

Haleon plc

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

Pfizer Inc.

City of registered office (if applicable)

New York

Country of registered office (if applicable)

United States of America

4. Details of the shareholder

Name

City of registered office

Country of registered office

Guaranty Nominees Limited

Bournemouth

United Kingdom

Wealth Nominees Limited

Lancing

United Kingdom

5. Date on which the threshold was crossed or reached

17-Jul-2022

6. Date on which Issuer notified

18-Jul-2022

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

32.000000

0.000000

32.000000

2,955,063,626

Position of previous notification (if applicable)

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

Ordinary Shares GB00BMX86B70

2,364,050,902

25.600000

Restricted ADRs

591,012,724

6.400000

Sub Total 8.A

2,955,063,626

32.000000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

 

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

 

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

 

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

 

12. Date of Completion

18-Jul-2022

13. Place Of Completion

New York, USA

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLUKURRUSUBAAR
Date   Source Headline
31st May 20244:47 pmRNSDisposal of the ChapStick brand completed
23rd May 20245:15 pmRNSDirector/PDMR Shareholding
20th May 20242:45 pmRNSHolding(s) in Company
20th May 20242:15 pmRNSDirector/PDMR Shareholding
17th May 20245:30 pmRNSHaleon
8th May 20245:15 pmRNSResults of Haleon 2024 Annual General Meeting
7th May 20249:30 amRNSEMTN programme: publication of base prospectus
1st May 202411:10 amRNSDirectorate Change
1st May 20247:00 amRNSHaleon 2024 Q1 Trading Statement
24th Apr 20247:00 amRNSAppointment of Dawn Allen as CFO
12th Apr 202412:00 pmRNSNotice of Annual General Meeting (AGM)
3rd Apr 202411:30 amRNSDirector/PDMR Shareholding
2nd Apr 20249:15 amRNSTotal Voting Rights and Capital
22nd Mar 202411:30 amRNSHolding(s) in Company
21st Mar 20246:00 pmRNSHaleon
21st Mar 20244:38 pmRNSTotal Voting Rights and Capital
21st Mar 20244:05 pmRNSClosing of Secondary Global Offering by Pfizer
20th Mar 20248:39 amRNSFinal prospectus supplement filed with the SEC
19th Mar 20247:00 amRNSPricing and upsize of Secondary Global Offering
18th Mar 202411:00 amRNSPreliminary prospectus supplement filed with SEC
18th Mar 20247:00 amRNSProposed Secondary Global Offering by Pfizer Inc.
15th Mar 20243:00 pmRNSPublication of Annual Report and Form 20-F 2023
14th Mar 20244:20 pmRNSDirector/PDMR Shareholding
12th Mar 20243:30 pmRNSDirector/PDMR Shareholding
5th Mar 20242:30 pmRNSDirector/PDMR Shareholding
29th Feb 20247:00 amRNSHaleon Preliminary 2023 Full Year Results
2nd Feb 20242:15 pmRNSDirector Declaration
25th Jan 20247:00 amRNSHaleon to sell ChapStick
18th Jan 20245:00 pmRNSHolding(s) in Company
17th Jan 20246:00 pmRNSHaleon
11th Jan 20241:00 pmRNSDirector/PDMR Shareholding
19th Dec 20231:00 pmRNSDirector/PDMR Shareholding
13th Dec 202310:30 amRNSDirector/PDMR Shareholding
10th Nov 20231:00 pmRNSDirector/PDMR Shareholding
2nd Nov 20237:00 amRNSHaleon 2023 Q3 Trading Statement
13th Oct 20233:30 pmRNSDirector/PDMR Shareholding
11th Oct 20233:00 pmRNSDirector/PDMR Shareholding
10th Oct 202311:00 amRNSHolding(s) in Company
6th Oct 20236:00 pmRNSHaleon
6th Oct 20232:30 pmRNSDirector/PDMR Shareholding
28th Sep 202311:00 amRNSDirector Declaration
13th Sep 20239:30 amRNSDirector/PDMR Shareholding
10th Aug 20231:00 pmRNSDirector/PDMR Shareholding
2nd Aug 20237:00 amRNSHaleon Half Year Results 2023
13th Jul 202311:00 amRNSDirector/PDMR Shareholding
12th Jun 20231:00 pmRNSDirector/PDMR Shareholding
16th May 20232:00 pmRNSHolding(s) in Company
16th May 20232:00 pmRNSHolding(s) in Company
12th May 20235:30 pmRNSHaleon
12th May 20234:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.